Physician profile
Virginia E Mclean
NPI 1255741864
$1,602.36
in general payments reported to CMS, 2019-2025
11 companies · $29.27 in 2025
The $29.27 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $192 · 2020: $138 · 2021: $220 · 2022: $961 · 2023: $62.19 · 2025: $29.27.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $91.46.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $91.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Momentis Surgical INC. | $887.00 | 2022 | |
| Abbvie INC. | $340.25 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $82.55 | 2019-2020 | |
| Myriad Women'S Health, INC. | $62.19 | 2023 | Myrisk |
| Aspira Women'S Health INC | $54.65 | 2022 | |
| Therapeuticsmd, INC. | $51.47 | 2021 | |
| Exeltis, USA INC. | $34.40 | 2020-2021 | |
| Lupin INC. | $31.96 | 2020 | |
| Astellas Pharma US INC | $29.27 | 2025 | Veozah |
| Coopersurgical, INC. | $17.64 | 2020 | |
| Dysis Medical, INC. | $10.98 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Virginia Mclean listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.